VSTM2L and cancer: V‐set and transmembrane domain containing two like, a novel modulator of neuroprotective activity. Overexpression of VSTM2L in a variety of cancer samples regulates IL‐4 signaling pathway, mainly enrichs in cell signal transduction, immune response, inflammatory response, calcium binding, and so forth.47